| ORIGINAL ARTICLE |
|
| Year : 2013 | Volume
: 33
| Issue : 2 | Page : 123-130 |
|
|
Evaluation of Brāhmī ghṛtam in children suffering from Attention Deficit Hyperactivity Disorder
Supriya Bhalerao1, Renuka Munshi1, Tanuja Nesari2, Heenal Shah3
1 Department of Clinical Pharmacology, TNMC and BYL Nair Ch. Hospital, Mumbai, Maharashtra, India
2 Department of Dravyaguna, Tilak Ayurved Mahavidyalaya, Pune, Maharashtra, India
3 Department of Psychiatry, TNMC and BYL Nair Ch. Hospital, Mumbai, Maharashtra, India
Correspondence Address:
Renuka Munshi
Department of Clinical Pharmacology, TNMC and BYL Nair Ch. Hospital, Mumbai Central, Mumbai 400 008, Maharashtra
India
 Source of Support: Nair Golden Jubilee Research Foundation, TNMC
& BYL Nair Ch. Hospital, Mumbai., Conflict of Interest: None  | Check |
DOI: 10.4103/0257-7941.139057
|
|
|
Introduction: Attention Deficit Hyperactivity Disorder (ADHD) is characterized by a persistent pattern of inattention and/or hyperactivity-impulsivity. In view of the adverse effects associated with psycho-stimulants used for the treatment of this disorder, efficacy of Brāhmīghṛtam was evaluated in this condition.
Materials and Methods: After following due ethical considerations, children of either sex between the age group of 6 and 12 years diagnosed to be suffering from mixed variety of ADHD as per The Diagnostic and Statistical Manual of Mental Disorders (DSM) IV criteria irrespective of other co-morbid psychiatric illnesses were recruited in the study. Initially a pilot study (n = 10) was carried out to confirm the efficacy of the identified dose of Brāhmīghṛtam. Using this dose, further therapeutic confirmatory study (n = 27) was carried out, wherein Brāhmīghṛtam was compared with methylphenidate. Effect on ADHD symptoms was assessed using the Dupaul ADHD rating scale and this was the main efficacy parameter.
Results: In the pilot exploratory study, Brāhmīghṛtam showed 66% decrease in total ADHD score. In the therapeutic confirmatory study, only 16% improvement was seen with Brāhmīghṛtam, which was similar to methylphenidate, standard treatment for ADHD that was used as a comparator in the present study. No side-effects were reported in both studies.
Conclusion: Our study thus has adequately demonstrated efficacy and safety of Brāhmīghṛtam in ADHD. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
